Sh ~ METROP~LIS
Total Page:16
File Type:pdf, Size:1020Kb
Ref: M H USec&Legal/2019/18 Date: July 15, 2019 To, Head, Listing Compliance Department Head, Listing Compliance Department SSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Plot No. C/1. G Block, Mumbai - 400 001 Sandra -Kurla Complex, Sandra (East), Mumbai- 400051 Scrip Code:542650 Script Symbol: METROPOLIS Dear Sir/Madam, Sub: Annual Report, Notice of 19th Annual General Meeting, Remote e-voting facility, Scrutinizer and Cut-off date. Pursuant to Regulation 34 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), the Annual Report of the Company along with the Notice of Annual General Meeting for the financial year 2018-19, is attached herewith, which is being dispatched I sent to the members by the permitted mode(s). The 191h Annual General Meeting of the members of the Company will be held on Tuesday, August 06, 2019 at Hall of Culture, Nehru Centre, Worli, Mumbai- 400 018 at 9.00 a.m. Further, pursuant to Section 108 of the Companies Act, 2013, read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended from time to time and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is providing to its members the facility to cast their votes by electronic means ("E-voting") on all resolutions set forth in the Notice. The instructions for E-voting are mentioned in the Notice. TheE-voting period would commence on Friday, August 02, 2019 and would end on Monday, August 05, 2019 (from 10.00 a.m. to 5.00 p.m. each day). During this period, the eligible members may cast their votes through electronic means in the manner specified in the Notice. The voting rights of Members shall be in proportion to the Equity Shares held by them, as on the cut-off date i.e. Tuesday, July 30, 2019. Further, Manish Ghia and Associates, Company Secretaries, Mumbai has been appointed as a Scrutinizer by the Company to Scrutinize the entire voting process in a fair and transparent manner. This is for your information and record purpose. Yours faithfully For Metropolis Healthcare Limited 3::!sh ~ Head Legal, Company Secretary & Compliance Officer Membership No.: F6742 Address: Metropolis Healthcare Limited, 250 D, Udyog Bhavan, Hind Cycle Lane, Worli, Mumbai - 400 030 INNER HEALTH REVEALED Metropolis Healthcare Limited Registered Office: 250 D. Udyog Bhavan, Hind Cycle Marg. Worli, Mumbai - 400 030. METROP~ LIS CIN: U73100MH2000PLCI92798. Tel: +91-22-3399 393916650 5555. The Pathology Specialist Email: [email protected] I Website: www.metropolisindia.com C entral Laboratory: 4th Floor. Commercial Building-lA, Kohlnoor Mall. Vidyavihar 0N), Mumbai • 400 070. Annual Report 2018-19 Metropolis Healthcare Limited | Limited Healthcare Metropolis Registered Office: 250-D, Udyog Bhavan, Hind Cycle Marg, Behind Glaxo, Worli, Mumbai – 400030 Customer Care: 022-33993939 2018-19 Annual Report Reaching out RESPONSIBLY Across the pages Corporate Overview Statutory Reports Reaching out responsibly 1 Management Discussions and Analysis 25 Know us 2 Boards Report 33 The Metropolis Brand Manifesto 4 Corporate Governance 45 Reaching out for a reliable cause 5 Our evolution 6 Financial Section Notable Recent Awards & Accolades 8 Corporate Profile 9 Standalone 96 Diagnosing financial numbers 10 Consolidated 167 Chairman’s Message 12 MD’s Message 14 Decoding the Pathology Industry 16 Customer Centricity: A warm Patient centric approach 17 Driven by Science And Innovation 18 Asset light model to realise more 19 Please find our online version at https:// Gearing up for ESG Indicators 20 www.metropolisindia.com/about- metropolis/investors Board of Directors 22 Management Team 23 Corporate Information 24 Or simply scan to download Investor information Listed on NSE/BSE since : April 15, 2019 BSE Code : 542650 NSE Symbol : METROPOLIS Bloomberg Code : METROHL:IN AGM Date : August 6, 2019 AGM Venue : Hall of Culture, Nehru Centre, Worli, Mumbai Disclaimer This document contains statements about expected future events and financials of Metropolis Healthcare Limited, which are forward-looking. By their nature, forward-looking statements require the Company to make assumptions and are subject to inherent risks and uncertainties. There is significant risk that the assumptions, predictions and other forward-looking statements may not prove to be accurate. Readers are cautioned not to place undue reliance on forward-looking statements as a number of factors could cause assumptions, actual future results and events to differ materially from those expressed in the forward-looking statements. Accordingly, this document is subject to the disclaimer and qualified in its entirety by the assumptions, qualifications and risk factors referred to in the Management’s Discussion and Analysis of this Annual Report. Reaching out responsibly A successful business is the right combination of right things at the right time. Every venture reaches that stage where channelling through new doors of newer opportunities become the way forward. It is imperative to feed a business’s curiosity by way of constant branching and expansion. We, at Metropolis, identified our expansionary stage. We evaluated where we stood and knew it was time to penetrate deeper into markets with tremendous potential. Diagnostic services demand responsible execution. Our promise of reliability, quality assurance and wide range of best-in-class services make us one of the preffered choices of our customers. Having been in the diagnostics industry for over 35 years, we are now ready to notch our business higher and explore growth avenues with better and wider range of services. So we prepared, we took the plunge and we decided to reach out responsibly. Revenue grew by #EBIDTA grew by *PAT grew by 18.1% 16.4% 16.2% ` 76,005.59 lakhs ` 20,734.11 lakhs ` 13,083.40 lakhs All figures are on consolidated basis and pertain to FY 2018-19 # EBIDTA is before CSR,one time share based and other expenses * PAT is before CSR, one-time share based and other expenses Know us Leading to leverage One of the leading Indian diagnostics company, suitably-positioned to leverage the expected growth in the Indian diagnostics industry. Metropolis Healthcare Limited (‘Metropolis’ or ‘MHL’ or ‘the Company’) is one of leading and renowned Indian diagnostics companies. The Company owns a chain of diagnostic centers MHL categorises across India, South Asia, Africa and the Middle East. Over the years, Metropolis has carved tests into a niche for itself. The Company enjoys a loyal Routine tests: customer base, reflecting its strength as a Blood chemistry analyses, blood cell brand offering superior diagnostic tests and counts and urine examination services. Semi-specialized: With its widespread operational network, Metropolis offers a comprehensive range of Thyroid function tests, viral and clinical laboratory tests and profiles. These bacterial cultures, histology, cytology tests and profiles are used for prediction, early and infectious disease tests detection, diagnostic screening, confirmation Specialized tests: and/or monitoring of the disease. Metropolis Coagulation studies, autoimmunity plays a pivotal role in raising the bar of tests, cytogenetics and molecular diagnostic accuracy, technological equipment, diagnostics. customer experience and research-driven empathetic service in the industry. The Company’s broad spectrum of services offer around 3,487 clinical laboratory tests and 530 profiles. Various test combinations, specific to a disease or disorder and wellness profiles used for health and fitness screening form a part of the Company’s service profile. 2 METROPOLIS HEALTHCARE LTD 96-243 FINANCIAL STATEMENTS Metropolis has invested in a variety of specialized tests and also adopted several advanced tests Brand Values and technologies introduced in 25-95 REPORTS STATUTORY the global market. As on date, the Company offers 2,799 specialized tests. One of the prime reasons that Guide Us behind the Company’s leading position in the diagnostics industry is its track record of introducing 01-24 OVERVIEW CORPORATE specialized tests. Vision To be a respected healthcare brand trusted by clinicians, patients and stakeholders. Positively impact lives of patients in their most anxious times and turn their anxiety in to assurance. Mission Statement Helping people stay healthy, by accurately revealing their inner health INTEGRITY IS IN OUR VEINS. EMPATHY IS IN OUR BLOOD. ACCURACY IS IN OUR DNA. WE ARE METROPOLIS. ANNUAL REPORT 2018-19 3 The Metropolis Brand Manifesto We are the pathology specialists. We believe in truths. We are convinced that every human being deserves to know truths, especially if they are about inner health. And our aim is to present these truths in the most human way possible. We are focused. We apply ourselves through processes and innovation to ensure that we get it right the first time, every time. We conduct millions of medical tests every minute globally and each of the tests are focused to deliver precision and accuracy. We employ our global expertise in research to provide the latest in pathology services. We make sure that inner health status is easy to understand for both patients and care givers. We are transparent in communication and in the way we conduct our business. We look at our customers as human beings and not sample numbers. We recognize that our work will go a long way in ensuring right health